Xilam Animation (EPA:XIL)

Aerovate Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	19	22	19	166	202	227
Market Cap Growth	15.10%	15.10%	-88.57%	-17.64%	-11.05%	5.72%
Enterprise Value	22	38	47	205	232	246
Last Close Price	3.21	3.79	3.96	34.25	41.60	46.85
PE Ratio	-	-	3.65	113.33	31.90	88.54
Forward PE	-	46.56	2.80	17.42	24.87	35.18
PS Ratio	0.70	0.82	0.42	3.96	5.65	10.24
PB Ratio	0.36	0.43	0.26	2.39	2.99	3.74
P/FCF Ratio	1.09	1.28	1.58	28.25	-	-
P/OCF Ratio	1.08	1.27	0.60	5.34	8.11	9.72
PEG Ratio	-	1.36	1.36	1.36	1.36	1.36
EV/Sales Ratio	0.84	1.42	1.03	4.88	6.48	11.12
EV/EBITDA Ratio	1.08	2.00	2.23	6.90	6.88	17.91
EV/EBIT Ratio	7.81	13.15	9.25	19.79	27.47	68.84
EV/FCF Ratio	1.31	2.20	3.91	34.82	-	-
Debt / Equity Ratio	0.19	0.19	0.29	0.55	0.54	0.46
Debt / EBITDA Ratio	0.46	0.46	0.92	1.21	1.08	1.92
Debt / FCF Ratio	0.56	0.56	1.77	6.53	-	-
Asset Turnover	0.23	0.23	0.31	0.28	0.26	0.18
Quick Ratio	0.87	0.87	0.83	0.76	0.83	0.79
Current Ratio	0.93	0.93	0.87	0.79	0.86	0.83
Return on Equity (ROE)	-42.57%	-42.57%	6.77%	1.96%	10.66%	4.84%
Return on Assets (ROA)	1.55%	1.55%	2.16%	4.28%	3.79%	1.82%
Return on Capital (ROIC)	2.29%	2.29%	3.12%	6.10%	5.48%	2.55%
Return on Capital Employed (ROCE)	4.30%	4.30%	5.40%	11.20%	7.90%	3.80%
Earnings Yield	-137.62%	-116.87%	27.38%	0.88%	3.14%	1.13%
FCF Yield	92.12%	78.24%	63.14%	3.54%	-3.44%	-0.26%
Buyback Yield / Dilution	-20.68%	-20.68%	0.22%	-0.09%	-0.18%	-0.05%

Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.